Prosus, Visa, and Prudential Financial scored exits as Remitly went public, with Prudential divesting $32.5m of shares through the offering.

Boston Scientific will pay $269m for the 84% of the thrombectomy technology developer that it does not currently own.

Oxygen therapy developer Aviv Scientific completed a $40m series B round led by Danel while drug delivery system developer Credence raised almost as much.

Alphabet-backed CRM software provider Freshworks floated above its range and now boasts a market cap of $13.5bn.

The IPO price will give the GV-backed restaurant management software provider a market capitalisation of about $20bn at the time of its $870m flotation.

The diabetes management system developer, a spinoff of Sarnoff Corporation, has filed to raise up to $75m in a Nasdaq offering.

UChicago spinout NowPow has been acquired by Unite Us for an undisclosed amount.

Daiichi Life helped sales technology provider BellFace take its total funding above $80m while ZKTube Labs and Boom Entertainment each raised $15m.

Oracle has committed $205m to an initial public offering for the DNA sequencing technology developer with a $410m target for its close.

SoftBank has divested 57 million of its 625 million shares in the NYSE-listed e-commerce marketplace, having invested $3bn between 2015 and 2018.